ELISA / EIA / RIA Kits · RIA kit · Cat. RK-019-06
Corticotropin Releasing Factor (CRF) (Human, Rat, Mouse, Canine, Feline) – RIA Kit
Supplied as 125 tubes per unit. Species: Canine, Feline, Human, Mouse, Rat. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | RK-019-06 |
|---|---|
| Product type | ELISA / EIA / RIA Kits · RIA kit |
| Peptide family | Corticotropin & CRF Peptides |
| Species | Canine, Feline, Human, Mouse, Rat |
| Unit size | 125 tubes |
| Sensitivity | 100.1 pg/ml |
| Specificity | Peptide % CRF (Human, Rat) 100 CRF (Ovine) 1.8 ACTH (Human) 0 LH-RH 0 PACAP-38 (Human, Rat, Ovine) 0 [Arg 8 ]-Vasopressin 0 Urocortin (Human) 0 Urocortin (Rat) 0 BNP-45 (Rat) 0 |
| Radioactivity | Each kit contains 1.5 µCi of Iodine 125. |
| Inter-Assay CV | <15% |
| Intra-Assay CV | <10% |
| Standard Curve | Contact us for technical specifications on this product. This package conforms to the 49 CFR173.421 for expected radioactive material limited quantity, N.O.S. UN2910. Cathepsin H functions as an aminopeptidase in secretory vesicles for production of enkephalin and galanin peptide neurotransmitters. Lu WD, Funkelstein L, Toneff T, Reinheckel T, Peters C, Hook V. J Neurochem. 2012;122(3):512-22. Fetal undernutrition induces overexpression of CRH mRNA and CRH protein in hypothalamus and increases CRH and corticosterone in plasma during postnatal life in the rat. Núñez H, Ruiz S, Soto-moyano R, et al. Neurosci Lett. 2008;448(1):115-9. Differential regulation of prostaglandin production mediated by corticotropin-releasing hormone receptor type 1 and type 2 in cultured human placental trophoblasts. Gao L, Lu C, Xu C, Tao Y, Cong B, Ni X. Endocrinology. 2008;149(6):2866-76. Amygdala protein kinase C epsilon regulates corticotropin-releasing factor and anxiety-like behavior. Lesscher HM, Mcmahon T, Lasek AW, et al. Genes Brain Behav. 2008;7(3):323-33. Influence of f-MLP, ACTH(1-24) and CRH on in vitro chemotaxis of monocytes from centenarians. Genedani S, Filaferro M, Carone C, et al. Neuroimmunomodulation. 2008;15(4-6):285-9. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats. Naert G, Maurice T, Tapia-arancibia L, Givalois L. Psychoneuroendocrinology. 2007;32(8-10):1062-78. Novel in vitro perfusion system for the determination of hypothalamic-pituitary-adrenal axis responses. Moidel MA, Belz EE, Czambel RK, Rubin RT, Rhodes ME. J Pharmacol Toxicol Methods. 2006;53(3):264-71. Continuous i.c.v. infusion of brain-derived neurotrophic factor modifies hypothalamic-pituitary-adrenal axis activity, locomotor activity and body temperature rhythms in adult male rats. Naert G, Ixart G, Tapia-arancibia L, Givalois L. Neuroscience. 2006;139(2):779-89. Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease. Björkqvist M, Petersén A, Bacos K, et al. Hum Mol Genet. 2006;15(10):1713-21. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. Wang B, Shaham Y, Zitzman D, Azari S, Wise RA, You ZB. J Neurosci. 2005;25(22):5389-96. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats. Kappeler L, Zizzari P, Grouselle D, Epelbaum J, Bluet-pajot MT. J Neuroendocrinol. 2004;16(12):980-8. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. Sudo N, Chida Y, Aiba Y, et al. J Physiol (Lond). 2004;558(Pt 1):263-75. Effects of electro-acupuncture on corticotropin-releasing factor in rats with experimentally-induced polycystic ovaries. Stener-victorin E, Lundeberg T, Waldenström U, Bileviciute-ljungar I, Janson PO. Neuropeptides. 2001;35(5-6):227-31. Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of CRH, corticotropin, and cortisol. Vesely DL, San miguel GI, Hassan I, Schocken DD. J Clin Endocrinol Metab. 2001;86(9):4244-9. Characterization of neuropeptide Y-mediated corticotropin-releasing factor synthesis and release from human placental trophoblasts. Robidoux J, Simoneau L, St-pierre S, Masse A, Lafond J. Endocrinology. 2000;141(8):2795-804. |
| Standard Range | 10 - 1280 pg/ml |
| Sample Extraction | Recommended |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Frequently asked
What is Corticotropin Releasing Factor (CRF) (Human, Rat, Mouse, Canine, Feline) – RIA Kit?
Corticotropin Releasing Factor (CRF) (Human, Rat, Mouse, Canine, Feline) – RIA Kit is a ria kit elisa / eia / ria kit listed under catalog number RK-019-06 in the Corticotropin & CRF Peptides family, canine / feline / human / mouse / rat sequence. It is supplied as 125 tubes per unit for in vitro laboratory research.
What is the intended use of RK-019-06?
This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.